gemcabene + simvastatin

Gemcabene + simvastatin is a combination drug regimen comprising **gemcabene**, a lipid-lowering agent that inhibits hepatic triglyceride and cholesterol synthesis, and **simvastatin**, an HMG-CoA reductase inhibitor (statin) that blocks cholesterol biosynthesis. This combination aims to achieve additional reductions in low-density lipoprotein cholesterol (LDL-C) and C-reactive protein (CRP) compared to statin alone. In clinical studies, gemcabene added to simvastatin provided significant, dose-dependent reductions in LDL-C and CRP for patients with hypercholesterolemia who needed further lipid lowering beyond statin monotherapy[1][2].